Advisors Asset Management’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$324K Sell
11,322
-4,021
-26% -$128K ﹤0.01% 1070
2026
Q1
$483K Buy
15,343
+327
+2% +$10.3K 0.01% 979
2025
Q4
$442K Buy
15,016
+4,341
+41% +$121K 0.01% 988
2025
Q3
$270K Buy
10,675
+3,065
+40% +$74.7K ﹤0.01% 1081
2025
Q2
$183K Buy
7,610
+4,196
+123% +$97.3K ﹤0.01% 1128
2025
Q1
$78.2K Buy
+3,414
New +$82.4K ﹤0.01% 1240

Other funds holding RTO

Advisors Asset Management's RTO Position: Q2 2026 in Review

Advisors Asset Management reduced its Rentokil (RTO) stake by 26% in Q2 2026, selling an estimated $128K and leaving 11,322 shares worth $324K. The position accounts for ﹤0.01% of the portfolio, ranked #1070.

Advisors Asset Management first reported a position in RTO in Q1 2025 and has held it in 6 quarters since. The position peaked at $483K in Q1 2026. 285 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Advisors Asset Management held 11,322 shares of Rentokil worth $324K as of Q2 2026.
  • Advisors Asset Management sold 4,021 Rentokil shares in Q2 2026, an estimated $128K.
  • Rentokil made up ﹤0.01% of Advisors Asset Management's portfolio in Q2 2026, its #1070 holding.
  • Advisors Asset Management first reported a position in Rentokil in Q1 2025 and has held it in 6 quarters since.
  • Advisors Asset Management's Rentokil position peaked at $483K in Q1 2026.
  • 285 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.